Age and sex differences on anti-hyperglycemic medication exposure and risk of newly diagnosed multiple sclerosis in propensity score matched type 2 diabetics

BACKGROUND: The association between exposure to anti-hyperglycemic medications (A-HgM) for Type 2 Diabetes Mellitus (T2D) treatment and Multiple Sclerosis (MS) in T2D patients is unclear. METHODS: This retrospective cohort analysis used the Mariner claims database. Patient records were surveyed for...

Descripción completa

Detalles Bibliográficos
Autores principales: Branigan, Gregory L., Torrandell-Haro, Georgina, Vitali, Francesca, Brinton, Roberta Diaz, Rodgers, Kathleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618986/
https://www.ncbi.nlm.nih.gov/pubmed/36325137
http://dx.doi.org/10.1016/j.heliyon.2022.e11196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618986/
https://www.ncbi.nlm.nih.gov/pubmed/36325137
http://dx.doi.org/10.1016/j.heliyon.2022.e11196

Ejemplares similares